0001140361-12-018101.txt : 20120329 0001140361-12-018101.hdr.sgml : 20120329 20120329161630 ACCESSION NUMBER: 0001140361-12-018101 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20120327 FILED AS OF DATE: 20120329 DATE AS OF CHANGE: 20120329 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: KIRK THOMAS F CENTRAL INDEX KEY: 0001258258 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-10670 FILM NUMBER: 12724147 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: HANGER ORTHOPEDIC GROUP INC CENTRAL INDEX KEY: 0000722723 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-SPECIALTY OUTPATIENT FACILITIES, NEC [8093] IRS NUMBER: 840904275 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 10910 DOMAIN DRIVE STREET 2: SUITE 300 CITY: AUSTIN STATE: TX ZIP: 78758 BUSINESS PHONE: 512-777-3800 MAIL ADDRESS: STREET 1: 10910 DOMAIN DRIVE STREET 2: SUITE 300 CITY: AUSTIN STATE: TX ZIP: 78758 FORMER COMPANY: FORMER CONFORMED NAME: SEQUEL CORP DATE OF NAME CHANGE: 19890814 FORMER COMPANY: FORMER CONFORMED NAME: CELLTECH COMMUNICATIONS INC DATE OF NAME CHANGE: 19860304 4 1 doc1.xml FORM 4 X0305 4 2012-03-27 0 0000722723 HANGER ORTHOPEDIC GROUP INC HGR 0001258258 KIRK THOMAS F 10910 DOMAIN DRIVE SUITE 300 AUSTIN TX 78758 1 1 0 0 CEO Common Stock 2012-03-27 4 S 0 6793 21.9641 D 592087 D Option to Buy 13.50 2004-01-02 2013-01-02 Common Stock 100000 100000 D Option to Buy 15.67 2005-01-02 2014-01-02 Common Stock 100000 100000 D Option to Buy 8.08 2006-01-03 2015-01-03 Common Stock 100000 100000 D The shares of common stock were sold to cover taxes incurred as a result of the vesting of restricted shares. These shares were sold at a range of sale prices from $21.86 to $22.00. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Includes (i) unvested restricted shares which total 20,000 shares from an initial grant of 20,000 shares of restricted stock made on March 7, 2012, (ii) unvested restricted shares which total 63,976 shares from an initial grant of 70,769 shares of restricted stock and performance shares made on March 25, 2011, (iii) unvested restricted shares and fully vested shares which total 103,700 shares from an initial grant of 115,000 shares of restricted stock and performance shares made on March 30, 2010, (iv) unvested restricted shares and fully vested shares that total 76,234 shares from an initial grant of 107,730 shares of restricted stock and performance shares made on November 13, 2008, (v) fully vested shares that total 75,036 shares from an initial grant of 120,000 shares of restricted stock and performance shares made on August 9, 2007, and (vi) fully vested shares that total 98,175 shares from an initial grant of 110,000 shares of restricted stock made on June 12, 2006. All remaining unvested restricted shares will continue to vest at a rate of 25% per year of the original grant amount on the anniversary date of the grant. This option vested over a four-year period from the date of grant and is now fully vested. /s/ Jessica Lochmann Allen, Attorney-in-Fact for Thomas F. Kirk 2012-03-29